Troy E. Wilson
2017
In 2017, Troy E. Wilson earned a total compensation of $1.7M as President and Chief Executive Officer at Kura Oncology, a 65% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $259,545 |
|---|---|
| Option Awards | $979,093 |
| Salary | $471,900 |
| Other | $10,574 |
| Total | $1,721,112 |
Wilson received $979.1K in option awards, accounting for 57% of the total pay in 2017.
Wilson also received $259.5K in non-equity incentive plan, $471.9K in salary and $10.6K in other compensation.
Rankings
In 2017, Troy E. Wilson's compensation ranked 6,255th out of 14,666 executives tracked by ExecPay. In other words, Wilson earned more than 57.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,255 out of 14,666 | 57th |
Division Manufacturing | 2,302 out of 5,772 | 60th |
Major group Chemicals And Allied Products | 730 out of 2,075 | 65th |
Industry group Drugs | 566 out of 1,731 | 67th |
Industry Pharmaceutical Preparations | 445 out of 1,333 | 67th |
Source: SEC filing on April 26, 2018.
Wilson's colleagues
We found two more compensation records of executives who worked with Troy E. Wilson at Kura Oncology in 2017.